1-4 of 4
Geert Berx, PhD
Close
Sort by
Journal Articles

ZEB2 and LMO2 Drive Immature T-Cell Lymphoblastic Leukemia Via Distinct Oncogenic Mechanisms

Steven Goossens, PhD, Jueqiong Wang, PhD, Cedric Tremblay, PhD, Pieter Van Vlierberghe, PhD, Geert Berx, PhD, Tom Taghon, PhD, Jody J Haigh, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3916.
https://doi.org/10.1182/blood-2018-99-111104
Published: 2018
Journal Articles

Oncogenic ZEB2 Activation Drives Sensitivity Towards LSD1 Inhibition in T-Cell Acute Lymphoblastic Leukemia

Steven Goossens, PhD, Sofie Peirs, MSc, Geert Berx, PhD, Pieter Van Vlierberghe, PhD, Jody J. Haigh, PhD
Journal: Blood
Blood (2016) 128 (22): 4027.
https://doi.org/10.1182/blood.V128.22.4027.4027
Published: 2016
Journal Articles

The EMT Modulator SNAI1 Drives AML Development Via Its Interaction with the Chromatin Modulator LSD1

Catherine L Carmichael, PhD, Steven Goossens, PhD, Jueqiong Wang, PhD, Thao Nguyen, PhD, Katharina Haigh, Geert Berx, PhD, Benjamin Kile, PhD, Jody J Haigh, PhD
Journal: Blood
Blood (2016) 128 (22): 2688.
https://doi.org/10.1182/blood.V128.22.2688.2688
Published: 2016
Journal Articles

Cyclin D2 Overexpression Recapitulates Mantle Cell Lymphoma in Mice

Tim Pieters, PhD, Steven Goossens, PhD, Sara T'Sas, Geert Berx, PhD, Jody J. Haigh, PhD, Pieter Van Vlierberghe, Prof
Journal: Blood
Blood (2016) 128 (22): 1748.
https://doi.org/10.1182/blood.V128.22.1748.1748
Published: 2016